Literature DB >> 20395437

RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats.

Shirish Paranjpe1, William C Bowen, George C Tseng, Jian-Hua Luo, Anne Orr, George K Michalopoulos.   

Abstract

Liver regeneration after a two-thirds partial hepatectomy (PHx) is a complex process requiring interaction and cooperation of many growth factors and cytokines and cross talk between multiple pathways. Along with hepatocyte growth factor and its receptor MET (HGF-MET), the epidermal growth factor receptor (EGFR) signaling pathway is activated within 60 minutes after PHx. To investigate the role of EGFR in liver regeneration, we used two EGFR-specific short hairpin silencing RNAs to inhibit EGFR expression in regenerating normal rat liver. Suppression of EGFR mRNA and protein was evident in treated rats. There was also a demonstrable decrease but not complete elimination of bromo-deoxyuridine incorporation and mitoses at 24 hours after PHx. In addition, we observed up-regulation of MET and Src as well as activation of the ErbB-3-ErbB-2-PI3K-Akt pathway and down-regulation of STAT 3, cyclin D1, cyclin E1, p21, and C/EBP beta. The decrease in the ratio of C/EBP alpha to C/EBP beta known to occur after PHx was offset in shEGFR-treated rats. Despite suppression of hepatocyte proliferation lasting into day 3 after PHx, liver weight restoration occurred. Interestingly, hepatocytes in shEGFR-treated rats were considerably larger when compared with ScrRNA-treated controls. The data indicate that although the MET and EGFR pathways are similar, the contributions made by MET and EGFR are unique and are not compensated by each other or other cytokines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395437      PMCID: PMC2877830          DOI: 10.2353/ajpath.2010.090605

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  70 in total

1.  ErbB2 and ErbB3 regulate amputation-induced proliferation and migration during vertebrate regeneration.

Authors:  Agustin Rojas-Muñoz; Shibani Rajadhyksha; Darren Gilmour; Frauke van Bebber; Christopher Antos; Concepción Rodríguez Esteban; Christiane Nüsslein-Volhard; Juan Carlos Izpisúa Belmonte
Journal:  Dev Biol       Date:  2008-12-24       Impact factor: 3.582

Review 2.  The epidermal growth factor receptor: from development to tumorigenesis.

Authors:  Maria Sibilia; Renate Kroismayr; Beate M Lichtenberger; Anuradha Natarajan; Manfred Hecking; Martin Holcmann
Journal:  Differentiation       Date:  2007-11       Impact factor: 3.880

Review 3.  The HER family and cancer: emerging molecular mechanisms and therapeutic targets.

Authors:  Natalia V Sergina; Mark M Moasser
Journal:  Trends Mol Med       Date:  2007-11-05       Impact factor: 11.951

4.  Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.

Authors:  Kelly L Mueller; Lauren A Hunter; Stephen P Ethier; Julie L Boerner
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

5.  Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members.

Authors:  D L Wheeler; S Huang; T J Kruser; M M Nechrebecki; E A Armstrong; S Benavente; V Gondi; K-T Hsu; P M Harari
Journal:  Oncogene       Date:  2008-02-25       Impact factor: 9.867

6.  Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings.

Authors:  Ekihiro Seki; Yuichi Kondo; Yuji Iimuro; Tetsuji Naka; Gakuhei Son; Tadamitsu Kishimoto; Jiro Fujimoto; Hiroko Tsutsui; Kenji Nakanishi
Journal:  J Hepatol       Date:  2007-11-05       Impact factor: 25.083

7.  Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly.

Authors:  Vasiliki Gkretsi; Udayan Apte; Wendy M Mars; William C Bowen; Jian-Hua Luo; Yu Yang; Yan P Yu; Ann Orr; René St-Arnaud; Shoukat Dedhar; Klaus H Kaestner; Chuanyue Wu; George K Michalopoulos
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

8.  The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation.

Authors:  Sanae Haga; Michitaka Ozaki; Hiroshi Inoue; Yasuo Okamoto; Wataru Ogawa; Kiyoshi Takeda; Shizuo Akira; Satoru Todo
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

9.  Effect of molecular therapeutics on liver regeneration in a murine model.

Authors:  George Van Buren; Anthony D Yang; Nikolaos A Dallas; Michael J Gray; Sherry J Lim; Ling Xia; Fan Fan; Ray Somcio; Yan Wu; Daniel J Hicklin; Lee M Ellis
Journal:  J Clin Oncol       Date:  2008-04-10       Impact factor: 44.544

10.  Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells.

Authors:  S Agarwal; C Zerillo; J Kolmakova; J G Christensen; L N Harris; D L Rimm; M P Digiovanna; D F Stern
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

View more
  28 in total

1.  New concepts in liver regeneration.

Authors:  Kimberly J Riehle; Yock Y Dan; Jean S Campbell; Nelson Fausto
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

2.  Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation.

Authors:  Shirish Paranjpe; William C Bowen; Wendy M Mars; Anne Orr; Meagan M Haynes; Marie C DeFrances; Silvia Liu; George C Tseng; Anastasia Tsagianni; George K Michalopoulos
Journal:  Hepatology       Date:  2016-10-01       Impact factor: 17.425

Review 3.  Cellular and molecular basis of liver regeneration.

Authors:  Sushant Bangru; Auinash Kalsotra
Journal:  Semin Cell Dev Biol       Date:  2020-01-22       Impact factor: 7.727

4.  Activation of inactive hepatocytes through histone acetylation: a mechanism for functional compensation after massive loss of hepatocytes.

Authors:  Yujun Shi; Huaiqiang Sun; Ji Bao; Ping Zhou; Jie Zhang; Li Li; Hong Bu
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

Review 5.  Liver regeneration: biological and pathological mechanisms and implications.

Authors:  George K Michalopoulos; Bharat Bhushan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-06       Impact factor: 46.802

6.  Autocrine-controlled formation and function of tissue-like aggregates by primary hepatocytes in micropatterned hydrogel arrays.

Authors:  Courtney M Williams; Geeta Mehta; Shelly R Peyton; Adam S Zeiger; Krystyn J Van Vliet; Linda G Griffith
Journal:  Tissue Eng Part A       Date:  2011-02-02       Impact factor: 3.845

Review 7.  The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis.

Authors:  Carmen Berasain; Matías A Avila
Journal:  J Gastroenterol       Date:  2013-12-10       Impact factor: 7.527

8.  Combined Systemic Disruption of MET and Epidermal Growth Factor Receptor Signaling Causes Liver Failure in Normal Mice.

Authors:  Anastasia Tsagianni; Wendy M Mars; Bharat Bhushan; William C Bowen; Anne Orr; John Stoops; Shirish Paranjpe; George C Tseng; Silvia Liu; George K Michalopoulos
Journal:  Am J Pathol       Date:  2018-07-20       Impact factor: 4.307

9.  Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.

Authors:  Jiansheng Huang; Andrew E Schriefer; Wei Yang; Paul F Cliften; David A Rudnick
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

10.  Role and regulation of PDGFRα signaling in liver development and regeneration.

Authors:  Prince K Awuah; Kari N Nejak-Bowen; Satdarshan P S Monga
Journal:  Am J Pathol       Date:  2013-03-23       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.